|
ºÇ½é¤Ï¡¢±ìÁð¤Î¥Ë¥³¥Á¥ó¤ÏÆÇ¤Ç¿ÈÂΤ˰¤¤¤È·öÓ䤷¡¢¥Ë¥³¥Á¥ó¤Ï¾¯Î̤ʤé¤ÐÇ«¤í͸ú¤Ç¤¢¤ë¤È¾ÚÌÀ¤µ¤ì¤ë¤È¡¢¼¡¤Ï¡¢»æ´¬¤¤¿¤Ð¤³¤Î»æ¤Ë¤Ï²½³ØÊª¼Á¤¬Æþ¤Ã¤Æ¤¤¤ë¤È¸À¤¤¡¢¼¡¤Ï±ìÁð¤Ë´Þ¤à¹áÎÁ¡Êº½Åü¤âÆþ¤Ã¤Æ¤¤¤ë¡Ë¤¬ÍÆÇ¤È¸À¤¤¡¢º£¤Ç¤ÏËüÉ¤θµ¤È¥×¥í¥Ñ¥¬¥ó¥À¤¬¤¬¤Ê¤êΩ¤Æ¤ë¡£
¤½¤ì¤Ê¤é¡¢¥¿¥Ð¥³¤ò¼«Ê¬¤Ç¼ï¤«¤é°é¤Æ¤¿ÍդʤéÂç¾æÉפʤϤº¡£¤½¤³¤Ç¡¢¥¿¥Ð¥³¤Î¼ï»Ò¤ò¹ØÆþ¤·¡¢¥Ù¥é¥ó¥À¤ÇÂ礤¯¤·¡¢¤½¤ÎÍÕ¤ò¿©¤Ù¤¿¤é¥Ë¥³¥Á¥ó¤òÀݼè¤Ç¤¤ë¤Î¤Ç¡¢¤½¤ì¤ò¸¡Æ¤¤·¤Æ¤ß¤¿¡£
Á°²óµ»ö
ǧÃξɼ£ÎÅÌô¡§¥¿¥Ð¥³ÊäÂÈÇ
¢¨ÊƹñÀ½Íµ¡ºÏÇÝ¡¦²½³ØÊª¼Á̵ź²Ã¤Î¤¿¤Ð¤³
JT¤ÇÈÎÇ䤷¤Æ¤¤¤Þ¤¹¡£
¥Ê¥Á¥å¥é¥ë ¥¢¥á¥ê¥«¥ó ¥¹¥Ô¥ê¥Ã¥È ¥ª¡¼¥¬¥Ë¥Ã¥¯ ¡¡²Á³Ê£±È¢£µ£²£°±ß ¡Ø¼Â¾Ú¡Ø±ìÁð¤Ï̵Îà¤ÎÌôºÞ¡Ù¡Ù¡¡2018/2/6(²Ð)
Cotinine: a potential new therapeutic agent against Alzheimer's disease.¡¡
¥³¥Á¥Ë¥ó¡Ê¥Ë¥³¥Á¥ó¤ÎÂÎÆâ¤Ç¤ÎÀ¸À®Êª¡Ë¡§¥¢¥ë¥Ä¥Ï¥¤¥Þ¡¼É¤ËÂФ¹¤ëÀøºßŪ¤Ê¿·¤·¤¤¼£ÎÅÌô¡£ Cotinine has been shown to be neuroprotective, to improve memory in primates as well as to prevent memory loss, and to lower amyloid-beta (A¦Â)) burden in AD mice.
¥³¥Á¥Ë¥ó¤Ï¡¢ÎîĹÎà¤Îµ²±¤ò²þÁ±¤·¡¢µ²±ÁÓ¼º¤òͽËɤ·¡¢AD¥Þ¥¦¥¹¤Î¥¢¥ß¥í¥¤¥É - ¥Ù¡¼¥¿¡ÊA¦Â¡ËÉé²Ù¤òÄã²¼¤µ¤»¤ë¤¿¤á¤Ë¡¢¿À·ÐÊݸîŪ¤Ç¤¢¤ë¤³¤È¤¬¼¨¤µ¤ì¤Æ¤¤¤ë¡£
Because of its beneficial effects on brain function, good safety profile, and nonaddictive properties, cotinine may represent a new therapeutic agent against AD.
¥³¥Á¥Ë¥ó¤Ï¡¢Ç¾µ¡Ç½¡¢Îɹ¥¤Ê°ÂÁ´À¥×¥í¥Õ¥¡¥¤¥ë¡¢¤ª¤è¤ÓÃé¼Â¤Ç¤Ê¤¤ÆÃÀ¤ËÂФ¹¤ë¤½¤Îͱפʸú²Ì¤Î¤¿¤á¤Ë¡¢AD¡Ê¥¢¥ë¥Ä¥Ï¥¤¥Þ¡¼É¡ˤËÂФ¹¤ë¿·¤¿¤Ê¼£ÎÅÌô¤Ç¤¢¤êÆÀ¤ë¡£ Cotinine¡¡¥³¥Á¥Ë¥ó
¥³¥Á¥Ë¥ó¤Ï¥¿¥Ð¥³ÍÕ¤ÎÀ®Ê¬¤Ç¤¢¤ê¡¢¥Ë¥³¥Á¥ó¤Î¼ç¤ÊÂå¼Õ»ºÊª¤Ç¤¢¤ê¡¢¥Ë¥³¥Á¥ó¤ÎÌó70〜80¡ó¤¬2Ãʳ¬¥×¥í¥»¥¹¤Ç¥³¥Á¥Ë¥ó¤ËÊÑ´¹¤µ¤ì¡¢°äÅÁÅªÇØ·Ê¤Ë°Í¸¤¹¤ë¡£
¥Ë¥³¥Á¥ó¤È¤½¤ÎÂå¼Õ»ºÊª¤Ç¤¢¤ë¥³¥Á¥Ë¥óÅù¤Ï¡¢AD¡¢¤¦¤ÄÉ¡¢¿´Åª³°½ý¸å¥¹¥È¥ì¥¹¾ã³²¡¢Åý¹ç¼ºÄ´¾É¤ª¤è¤Ó¥È¥¥¥ì¥Ã¥È¾É¸õ·²¤Î¤è¤¦¤Ê¿À·Ð¤ª¤è¤ÓÀº¿À¾ã³²¤Î¼£ÎŤËͱפʸú²Ì¤ò¼¨¤·¤¿ ¥¿¥Ð¥³¤ÎÍդˤÏÁêÅö¤Ê¥Ë¥³¥Á¥ó¤ò´Þ¤à¡£¸Î¤Ë¡¢ÍդäѤò£±Ëç¤â¿©¤Ù¤¿¤éÅݤì¤ë¤è¤¦¤À¡£Á³¤·¡¢Àè¶î¼Ô¤¬¤¤¤¿¡£Èà¤Ï¡¢¥¿¥Ð¥³¤ÎÍÕ¤òÀéÀÚ¤ê¤Ë¤·¤Æ¡¢¤Û¤ó¤Î¤Á¤ç¤Ã¤Ô¤ê¿©¤Ù¤ë¤È¤¤¤¦¤â¤Î¡£
⤷¡¢Èà¤Ï¥Ø¥Ó¡¼¥¹¥â¡¼¥«¡¼¤Ç¤Ê¤¤¸Î¤Ë¡¢¥¿¥Ð¥³¤ÎÍÕ¤«¤éÀݼ褷¤¿¥Ë¥³¥Á¥ó¤Î¸ú²Ì¤ò³Îǧ½ÐÍè¤ë¤Þ¤Ç¤Ë¤Ï»ê¤Ã¤Æ¤¤¤Ê¤¤¡£
Àè¶î¼Ô¤Î¼ÂÁ©Îã
¡Ú¿©¤Ù¤ë¤¿¤Ð¤³Âè°ìÃÆ¡ÛÀ¸¤Î¥¿¥Ð¥³¤ÎÍÕ¤òÀéÀÚ¤ê¤Ë¤·¤Æ¡¢¥Õ¥£¥Ã¥·¥å¥Õ¥é¥¤¥µ¥ó¥Éºî¤Ã¤Æ¤ß¤¿¡ÚÂè»°¤Î¤¿¤Ð¤³¡Û
¤½¤ì¤Ê¤é¡¢¥Ø¥Ó¡¼¥¹¥â¡¼¥«¡¼¤Î»ä¤Ê¤é¤Ð¼Â¸³Âæ¤È¤·¤ÆÅ¬ÀڤǤ¢¤ë¤È¹Í¤¨¡¢²Ö¤Î´Ñ¾ÞÍÑ¥¿¥Ð¥³¤Î¼ï¤ò¹ØÆþ¤·¡¢¥Ù¥é¥ó¥À¤Ç°é¤Æ¡¢²Ö¤ò°¦¤Ç¤Ê¤¬¤é¡¢ÍÕ¤ò¤Û¤ó¤Î£±ËçĺÂפ·¡¢ÀéÀÚ¤ê¤Ë¤·¡¢ËèÆü¤½¤Î¤Ò¤È¤«¤±¤é¤º¤Ä¿©¤Ù¤ë¤³¤È¤Ë¤·¤¿¡£
¤³¤ì¤«¤é¼ï¤òÇŤ¡¢²Æ¤´¤í¤Ë¤Ï·ë²Ì¤ò½Ð¤»¤Æ¤³¤³¤Ç¸øÉ½½ÐÍè¤ë¤â¤Î¤È»×¤¦¡£
¿¢Êª¤È¤·¤Æ¤Î¡Ö¥¿¥Ð¥³¡×¡ÊJT¡Ë
¥Ê¥¹²Ê¤Î¿¢Êª
¿¢Êª¤È¤·¤Æ¤Î¥¿¥Ð¥³¤Ï¥Ê¥¹²Ê¥¿¥Ð¥³Â°¤ËʬÎव¤ì¤Æ¤¤¤Þ¤¹¡£Æ±¤¸¥Ê¥¹²Ê¤Î¿¢Êª¤Ç¤¢¤ë¥Ê¥¹¤ä¥È¥Þ¥È¡¢¥¸¥ã¥¬¥¤¥â¤Ê¤É¤ÈƱÍͤ˥¢¥á¥ê¥«ÂçΦ¤ò¸¶»ºÃϤȤ·¡¢À¤³¦³ÆÃϤǺÏÇݤµ¤ì¤Æ¤¤¤Þ¤¹¡£¸½ºß¡¢µÊ±ì¤ÎÍÑÅӤǺÏÇݤµ¤ì¤Æ¤¤¤ë¤Î¤Ï¡¢¼ç¤Ë¥Ë¥³¥Á¥¢¥Ê¡¦¥¿¥Ð¥«¥à¤È¥Ë¥³¥Á¥¢¥Ê¡¦¥ë¥¹¥Á¥«¤Î2¼ïÎà¤Ç¤¹¡£ ¥Ë¥³¥Á¥Ë¥¢¡Ê¥Ê¥¹²Ê¥¿¥Ð¥³Â°¡¢Â¿Ç¯Áð¡ËºÏÇÝ¥«¥ì¥ó¥À¡¼¡ÊNHK¼ñÌ£¤È±à·Ý¡Ë
¥Ù¥é¥ó¥À¤Ç¤Î¼ï¤Þ¤¤Î¥Ý¥¤¥ó¥È
£±¡Ë¼ï»Ò¤ÏÈùγ»Ò¤â¤É¤¤ÇÈó¾ð¤ËºÙ¤«¤¤¡£
£²¡ËʤÅڤϸ·¶Ø¡£ÅÚ¤ÎÃæ¤Ç¤Ïȯ²ê¤·¤Ê¤¤¡£
£³¡ËÅÚ¤ÎɽÌ̤¬´¥Á礷¤ä¤¹¤¤¤Î¤Ç¡¢¥ß¥ËȡʥݥåÈÅù¡Ë¤ò¥µ¥é¥ó¥é¥Ã¥×¤Çʤ¤¦¡£
£´¡ËÆü¸÷¤ò¤è¤¯Íá¤Ó¤»¤ë¡£
£µ¡Ëȯ²ê¤Ï½Õ¤Ï£±£°Æü¡¢²Æ¾ì¤Ï£´ÆüÁ°¸å¡£
¼ï»Ò¤ÎÁªÂò
£±¡Ë¥¿¥Ð¥³Â°¤Ë¤Ï¿§¡¹¤Ê¼ïÎब¤¢¤ë¤¬¡¢°é¤ÆÊý¤Î´ðËÜ¤ÏÆ±¤¸¡£
£²¡Ë¼ïÎà¤Ë¤è¤Ã¤Æ¤Ï¡¢Çؾ椬·Ú¤¯£±£í¤òͤ¨¤ë¤â¤Î¤¬Â¿¤¯¤¢¤ë¤¬¡¢¥Ù¥é¥ó¥ÀÍѤȤ·¤Æ¤Ï£±£í̤Ëþ¤Î¤â¤Î¤òÁªÂò¤¹¤ëÊý¤¬Îɤ¤¡£
¼ï»Ò¤Î¹ØÆþÀè¡ÊÄÌÈΡË
¡Ø¥Ë¥³¥Á¥¢¥Ê¼ï»ÒÈÎÇä¡Ù¤Ç¸¡º÷¡£
Î㣱¡Ë¥¿¥¥¤¤Ç¤â¥Í¥Ã¥ÈÄÌÈΤò¤·¤Æ¤¤¤ë¡££±£°£°Î³¤Ç£³£²£´±ß¡Ê²ñ°÷¤Î¾ì¹ç¤Ï£²£¹£±±ß¡Ë¤Ç¡¢²ñ°÷ÅÐÏ¿¤ò¤·¡¢¥«¡¼¥É·èºÑ¤Ë¤¹¤ë¤ÈÁ÷ÎÁ̵ÎÁ¡£
Î㣲¡Ë¥Þ¥ë¥·¥§ÀĶõ
Î㣳¡Ë¥½¥¯¥é¥Æ¥¹¤Î±ìÁð
¥ª¥ê¥¨¥ó¥ÈÍÕ¡¡¥×¥ê¥ì¥Ã¥×¤Î¼ï»Ò¡¢ºß¸Ëͤê
ÆÃµ»ö¹à
£±¡Ë¥¿¥Ð¥³¤ÎÍդΤߤ¬ÌÜŪ¤Ê¤é¡¢²Ö¤¬ºé¤¯Á°¤Ë¤Ä¤Ü¤ß¤òÀÚ¤êÍî¤È¤¹¡£
£²¡Ë²Ö¤Ï£µ¥ö·î´Öºé¤¯¡£¼ï»Ò¤¬Íߤ·¤¤¾ì¹ç¡¢°ìÉô¤Î²Ö¤ò¤·¤Ü¤ó¤Ç¤â»Ä¤·¤Æ¤ª¤¯¡£
£³¡Ë¾®¤µ¤¤¤ª»Ò¤µ¤ó¤¬¤¤¤ë²ÈÄí¤Ç¤ÏºÏÇݤ·¤Ê¤¤Êý¤¬¤¤¤¤¡£
¾°¡¢¥Ë¥³¥Á¥¢¥Ê¤Î°é¤ÆÊý¡¦ºÏÇÝÊýË¡¤Ë¤Ä¤¤¤Æ¤Ï¡¢²¼µ¤ÎNHK¤Î¥µ¥¤¥È¤â¤´Í÷¤¯¤À¤µ¤¤¡£
½ñ¸Ë¡Ø¥¢¥ë¥Ä¥Ï¥¤¥Þ¡¼¡¦Ç§Ãξɡ١¡Ìܼ¡
|
²áµî¤ÎÅê¹ÆÆüÊÌɽ¼¨
[ ¥ê¥¹¥È | ¾ÜºÙ ]
2019ǯ03·î28Æü
Á´1¥Ú¡¼¥¸
[1]
Á´1¥Ú¡¼¥¸
[1]



